| 4h ago | | ABBOTT LABORATORIES: Abbott to Present at Deutsche Bank 38th Annual Health Care.. |
| 1d ago | | ABBOTT LABORATORIES: Abbott Announces CE Mark for World's Longest Coronary Drug.. |
| 2d ago | DJ | Royalty Pharma Raises Takeover Bid for Elan |
| 05/14 | DJ | AbbVie, Alvine Pharma to Collaborate on Investigational Drug for Celiac Disea.. |
| 05/10 | DJ | AbbVie Chief Scientific Officer John Leonard to Retire |
| 05/09 | | ABBOTT LABORATORIES: Abbott Announces CE Mark for Test to Aid Doctors with Diag.. |
| 05/08 | | ABBOTT LABORATORIES: Abbott to Present at UBS Global Healthcare Conference |
| 04/30 | DJ | BOND REPORT: Apple Prices $17 Bln Bond Deal To Strong Demand |
| 04/30 | DJ | BOND REPORT: Apple Launches $17 Bln Bond Deal |
| 04/30 | DJ | BOND REPORT: Apple Launches $17 Bln Bond Deal |
| 04/30 | DJ | BOND REPORT: Apple Launches $17 Bln Bond Deal |
| 04/30 | DJ | BOND REPORT: Apple Sees High Demand For Bond Offering |
| 04/30 | DJ | Auction of Brazilian Drug Company Ache Stalls on Differences Among Family Own.. |
| 04/30 | DJ | Auction of Brazilian Drug Company Ache Stalls on Differences Among Family Own.. |
| 04/26 | DJ | AbbVie 1st-Quarter Profit Rises 9.6% on Strong Sales of Humira |
| 04/26 | DJ | AbbVie Profit Rises, Boosted by Humira Sales |
| 04/26 | DJ | AbbVie 1st-Quarter Profit Rises 9.6% on Strong Sales of Humira |
| 04/23 | DJ | Health-Care Companies Report Slowdown in Patient Visits |
| 04/22 | | Ahead of reform, medical care slowdown hits companies |
| 04/22 | | Analysis - Ahead of reform, medical care slowdown hits U.S. companies |
| 04/18 | | ABBOTT LABORATORIES: Abbott Announces FDA Approval and U.S. Launch of the TECNI.. |
| 04/17 | DJ | 'New Abbott' Labs Sees Sales Boost From Emerging Markets |
| 04/17 | DJ | Abbott 1st-Quarter Profit Fell 56% On Spinoff; Remaining Operations See Growt.. |
| 04/17 | | ABBOTT LABORATORIES: Abbott Reports First-Quarter 2013 Results |
| 04/16 | | ABBOTT LABORATORIES: Abbott Introduces Next Generation Laboratory Automation So.. |
| 04/15 | DJ | ABBOTT LABORATORIES: Recalls FreeStyle InsuLinx Glucose Meters |
| 04/15 | DJ | ABBOTT LABORATORIES: Recalls FreeStyle InsuLinx Glucose Meters |
| 04/15 | | ABBOTT LABORATORIES: Abbott Initiates Voluntary Recall of FreeStyle InsuLinx® B.. |
| 04/12 |  | ABBOTT LABORATORIES: quaterly earnings release |
| 04/12 | DJ | Elan Investors Back Buyback, As Takeover Speculation Swirls |
| 04/11 | | ABBOTT LABORATORIES: ex-dividend day |
| 04/10 | | ABBOTT LABORATORIES: Abbott's Galectin-3 Test Provides Doctors in Europe with N.. |
| 04/05 | DJ | U.S. HOT STOCK FUTURES: Hot stocks to watch |
| 04/04 | DJ | U.S. Appeals Court Reverses $593 Million Award Against J&J |
| 04/04 | DJ | Appeals Court Reverses $593 Million Award Against J&J |
| 04/04 | | Court reverses $482 million stent case against Cordis |
| 04/04 | DJ | U.S. Appeals Court Reverses $593 Million Award Against J&J |
| 04/02 | | Exclusive - Pfizer, Novartis, Abbott weigh bids for Brazil's Ache - sources |
| 04/02 | | Big Pharma down, not out, after Indian patent blow |
| 04/02 | | Analysis - Big Pharma down, not out, after Indian patent blow |
| 04/01 | | ABBOTT LABORATORIES: Abbott Hosts Conference Call for First-Quarter Earnings |
| 03/28 | | ABBOTT LABORATORIES: New Abbott Test Can Help Doctors Detect the Presence of Tw.. |
| 03/25 | | ABBOTT LABORATORIES: FDA Advisory Committee Votes Favorably on Abbott's Minimal.. |
| 03/22 | DJ | ABBOTT LABORATORIES: Abbott Labs Issues Safety Alert on MitraClip Heart-Valve D.. |
| 03/22 | DJ | ABBOTT LABORATORIES: Abbott Labs Issues Safety Alert on MitraClip Heart-Valve D.. |
| 03/20 | | ABBOTT LABORATORIES: FDA Advisory Committee Votes Favorably on Abbott's Minimal.. |
| 03/20 | DJ | ABBOTT LABORATORIES: FDA Panel Votes 5-3 on Benefits of Abbott Heart Device Mit.. |
| 03/18 | DJ | AbbVie CEO 2012 Pay Up 40%, but Lags General Counsel's Total |
| 03/18 | DJ | ABBOTT LABORATORIES: FDA Recommends Against Approving Abbott's Mitraclip Heart .. |
| 03/18 | DJ | AbbVie CEO 2012 Compensation Valued at $7.9 Million, Up More Than 40% |
| 03/18 | DJ | ABBOTT LABORATORIES: FDA Recommends Against Approving Abbott's Mitraclip Heart .. |
| 03/11 | | ABBOTT LABORATORIES: New Data Reinforce Strong Long-Term Clinical Performance o.. |
| 03/10 | | AbbVie seeks to stop EU agency releasing drug data |
| 03/10 | | ABBOTT LABORATORIES: Abbott's Minimally Invasive MitraClip ® System for Mitral .. |
| 03/07 | | ABBOTT LABORATORIES: Abbott to Present at Barclays Capital 2013 Global Healthca.. |
| 03/05 | | ABBOTT LABORATORIES: Abbott Introduces Nutrition for Active Kids - Kidz ZonePer.. |
| 03/05 | | ABBOTT LABORATORIES: Abbott Introduces Nutrition for Active Kids - Kidz ZonePer.. |
| 03/05 | DJ | Rise of Generics, Specialty Drugs Prompt Shift in Drug Spending |
| 03/04 | DJ | Elan Sweetens Shareholder Deal |
| 02/25 | DJ | Royalty Pharma Offers $6.55 Billion for Elan |
| 02/25 | DJ | Royalty Pharma Offers $6.55 Billion for Elan |
| 02/21 | | ABBOTT LABORATORIES: Abbott to Collaborate with Janssen and Pharmacyclics on De.. |
| 02/21 | DJ | Gimme Credit's Top Bonds List Led by Abbvie, Entergy, Phillips 66 |
| 02/19 | DJ | Owens & Minor Names Industry Veteran Meier as Chief Financial Officer |
| 02/15 | | ABBOTT LABORATORIES: Abbott Declares 357th Consecutive Quarterly Dividend |
| 02/15 | DJ | AbbVie Authorizes $1.5 Billion Stock-Buyback Plan |
| 02/13 | DJ | Japan GDP Shrinks for Third-Straight Quarter |
| 02/12 | | ABBOTT LABORATORIES: New Survey Reveals Eight in 10 Fitness Enthusiasts Are Not.. |
| 02/12 | DJ | GlaxoSmithKline, Others Weighing $3 Billion-$4 Billion Deal For Brazilian Dru.. |
| 01/30 | DJ | AbbVie Sees Humira Growth Offsetting Heart-Drug Weakness |
| 01/30 | DJ | AbbVie Issues Optimistic 2013 View on Strong Humira Sales |
| 01/23 | | Abbott results bode well for spun-off AbbVie |
| 01/23 | DJ | Abbott Labs 4th-Quarter Profit Fell 35% on Debt-Extinguishment Charges |
| 01/23 | DJ | Abbott Labs 4th-Quarter Profit Fell 35% on Debt-Extinguishment Charges |
| 01/23 | DJ | Correction to Abbott Labs Earnings Story |
